Institutional Ownership Acumen Pharmaceuticals, Inc. (ABOS)
This table provides information about the institutional ownership of Acumen Pharmaceuticals, Inc. (ABOS). We have compiled data on the 72 institutions that hold shares in the stock, with a total of 36.2 Million shares, which have been reported (via 13F filing form) to have a value of $64.5 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
147,148
shares
|
$261,923
0.0% of portfolio
|
Q3 2025
Reduced 56.03%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
106,678
shares
|
$189,886
0.0% of portfolio
|
Q2 2025
Reduced 79.53%
|
|
|
Catalyst Financial Partners LLC
Boston, MA |
Nov 10, 2025 Q3 2025 |
89,699
shares
|
$159,664
0.02% of portfolio
|
Q2 2023
New holding
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
78,446
shares
|
$139,633
0.0% of portfolio
|
Q3 2024
Added 38.44%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Nov 13, 2025 Q3 2025 |
77,920
shares
|
$138,697
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
64,954
shares
|
$115,618
0.0% of portfolio
|
Q3 2025
Reduced 0.32%
|
|
|
Boothbay Fund Management, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
51,042
shares
|
$90,854
0.0% of portfolio
|
Q4 2024
Reduced 1.29%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 12, 2025 Q3 2025 |
43,524
shares
|
$77,472
0.0% of portfolio
|
Q1 2025
Reduced 55.6%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
32,881
shares
|
$58,528
0.0% of portfolio
|
Q3 2025
Reduced 42.87%
|
|
|
Gsa Capital Partners LLP
London, X0 |
Nov 07, 2025 Q3 2025 |
32,103
shares
|
$57,143
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
30,841
shares
|
$54,896
0.0% of portfolio
|
Q3 2025
Reduced 67.34%
|
|
|
Intrepid Financial Planning Group LLC
Carmel, IN |
Nov 13, 2025 Q3 2025 |
30,150
shares
|
$53,667
0.02% of portfolio
|
Q3 2023
Added 49.63%
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
29,991
shares
|
$53,383
0.0% of portfolio
|
Q2 2025
Reduced 58.5%
|
|
|
Catalyst Funds Management Pty LTD
Sydney Nsw, C3 |
Nov 12, 2025 Q3 2025 |
29,600
shares
|
$52,688
0.01% of portfolio
|
Q3 2025
New holding
|
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
Nov 14, 2025 Q3 2025 |
23,904
shares
|
$42,549
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Pinnacle Associates LTD
|
Nov 12, 2025 Q3 2025 |
18,020
shares
|
$32,075
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Pinnacle Wealth Management Advisory Group, LLC
|
Oct 20, 2025 Q3 2025 |
18,020
shares
|
$32,075
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Clune & Associates, Ltd.
Chicago, IL |
Oct 17, 2025 Q3 2025 |
16,500
shares
|
$29,370
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
Point72 Asia (Singapore) Pte. Ltd.
Singapore, U0 |
Nov 14, 2025 Q3 2025 |
16,044
shares
|
$28,558
0.0% of portfolio
|
Q3 2025
Reduced 24.82%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Nov 17, 2025 Q3 2025 |
16,001
shares
|
$28,481
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Hrt Financial LP
New York, NY |
Nov 14, 2025 Q3 2025 |
14,014
shares
|
$24,944
0.0% of portfolio
|
Q3 2025
Reduced 55.41%
|
|
|
Pfg Investments, LLC
Woodbury, NY |
Oct 31, 2025 Q3 2025 |
11,500
shares
|
$20,470
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Savant Capital, LLC
|
Nov 04, 2025 Q3 2025 |
11,045
shares
|
$19,660
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Integrated Wealth Concepts LLC
|
Nov 14, 2025 Q3 2025 |
10,179
shares
|
$18,118
0.0% of portfolio
|
Q3 2025
Reduced 2.37%
|
|
|
Group One Trading, L.P.
Chicago, IL |
Nov 12, 2025 Q3 2025 |
7,798
shares
|
$13,880
0.0% of portfolio
|
Q3 2025
Reduced 8.52%
|
|